Trial intelligence / Profile preview

Pulsed levosimendan infusions in outpatients with advanced heart failure

2008-007407-86Phase 3Completed

Sponsor
Medical University of Innsbruck
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic heart failure (CHF) comparing Levosimendan pulsed infusion with Placebo pulsed infusion (2 arms). Primary endpoint: Composite functional capacity and quality of life response at 28 weeks. Started Jul 2009; status: completed.

02

Drugs

levosimendan
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on 2008-007407-86.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007407-86.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call